Literature DB >> 18335506

A PCR/restriction digestion assay for the detection of the transcript variants 1 and 2 of POU5F1.

Ioannis Panagopoulos1, Emely Möller, Margareth Isaksson, Fredrik Mertens.   

Abstract

POU5F1 has two alternatively spliced transcripts: a long (variant 1, NM_002701) and a short (variant 2, NM_203289) transcript. Only variant 1 is a key regulator of pluripotency. Hence, it is important to be able to distinguish this transcript from variant 2 and from the many pseudogenes present in the genome. Previous studies on the expression of POU5F1 were, however, usually carried out without considering the existence of the two transcripts and the pseudogenes which could be the source of false positive RT-PCR amplification. Here, we establish an RT-PCR/restriction digestion analysis to distinguish variant 1 of POU5F1 from variant 2 and all its currently known pseudogenes. Variant 1 has ApaI and Tsp45I restriction sites, which are not present in the pseudogenes or in variant 2. Thus, ApaI- and Tsp45I- digestions of POU5F1 PCR fragment, amplified with primers flanking these sites, are sufficient to identify the true variant 1 of POU5F1. To study the expression of variant 2 of POU5F1, two forward primers in the 5'-region that are not present in variant 1 were combined with reverse primers located in exon 3 of POU5F1 common to both transcripts. The assay was applied on 10 samples from peripheral blood leukocytes and commercially available ready-cDNAs from leukocytes and testis. We found that only variant 2 was expressed in leukocytes and testis and that the extracted RNA was not completely DNA free, despite DNAse treatment. This trace amount of DNA is a source of false positive RT-PCR amplifications. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045-2257/suppmat.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18335506     DOI: 10.1002/gcc.20555

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.

Authors:  Kyung-Mi Bae; Zhen Su; Carole Frye; Steve McClellan; Robert W Allan; Joseph T Andrejewski; Vicky Kelley; Marda Jorgensen; Dennis A Steindler; Johannes Vieweg; Dietmar W Siemann
Journal:  J Urol       Date:  2010-03-19       Impact factor: 7.450

Review 2.  Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.

Authors:  Xia Wang; Jianwu Dai
Journal:  Stem Cells       Date:  2010-05       Impact factor: 6.277

3.  Specific detection of OCT4 isoforms in inflammatory bowel disease.

Authors:  Maria Maragkoudaki; Anna Vaiopoulou; George E Theodoropoulos; Evangelia Legaki; Leonardo A Sechi; George Karamanolis; George Zografos; Maria Gazouli
Journal:  Gut Pathog       Date:  2015-10-01       Impact factor: 4.181

4.  Colon cancer cell differentiation by sodium butyrate modulates metabolic plasticity of Caco-2 cells via alteration of phosphotransfer network.

Authors:  Ljudmila Klepinina; Aleksandr Klepinin; Laura Truu; Vladimir Chekulayev; Heiki Vija; Kaisa Kuus; Indrek Teino; Martin Pook; Toivo Maimets; Tuuli Kaambre
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.240

5.  Expression and differentiation between OCT4A and its Pseudogenes in human ESCs and differentiated adult somatic cells.

Authors:  Mojca Jez; Sakthikumar Ambady; Olga Kashpur; Alexandra Grella; Christopher Malcuit; Lucy Vilner; Primoz Rozman; Tanja Dominko
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.